Inventor · disambiguated record
Markus Heitzmann
Also filed as: HEITZMANN MARKUS
3 granted patents·4 pending applications·22 citations·filing 1993–2024
65Inventor score
Top patents by PatentIndex Score
7 records- 0175US2025034241A1Selective reduction of cysteine residues in il-17 antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0269US6770762B2Process for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazoleBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Aug 3, 2004·5 cites·11 claims
- 0366US2022315650A1Selective reduction of cysteine residues in il-17 antibodiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0453US11292833B2Selective reduction of cysteine residues in IL-17 antibodiesNOVARTIS AG·Filed 2015·Granted Apr 5, 2022·0 cites·25 claims
- 0553US6165746APreventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteriaNOVARTIS AG·Filed 1993·Granted Dec 26, 2000·17 cites·13 claims
- 0644US2004225129A1Process for preparing and purifying 1,7'-dimethyl-2'-propyl-2,5'-bi-1H-benzimidazoleBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 0731US2007149490A1process for the extraction of betulinic acidPUDER CARSTEN H·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Heitzmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →